Alice T Shaw

8PUBLICATIONS
96CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 06, 2026
Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer.

|Jun 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized study.

|Apr 28, 2025
Response and Resistance to RAS Inhibition in Cancer.

Richard Y Ebright, Julien Dilly, Alice T Shaw

|May 31, 2024
Lorlatinib Versus Crizotinib in Patients With Advanced <i>ALK</i>-Positive Non-Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study.

Benjamin J Solomon, Geoffrey Liu, Enriqueta Felip

|Jul 05, 2023
Therapy-induced APOBEC3A drives evolution of persistent cancer cells.

Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi

|Apr 06, 2023
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.

Arvind Ravi, Matthew D Hellmann, Monica B Arniella

Pageof 2

Frequent Collaborators

3 joint publications

Jessica J Lin

2 joint publications

Pasi A Jänne

1 joint publications

Marc Pelletier

1 joint publications

Jie Yang